Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 14 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Solitary Pulmonary Nodule 1 Rectal Neoplasms 1 Pain, Postoperative 1 Lymphedema 1 Lung Neoplasms 1 Carcinoma, Ductal 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Anatomic Stage II Breast Cancer AJCC v8 1 Adenocarcinoma of Lung 1

Interventions

Capecitabine 22 Oxaliplatin 19 Fluorouracil 16 Radiotherapy 11 Leucovorin 10 Cetuximab 9 Nivolumab 7 Bevacizumab 6 sintilimab 5 Specimen Handling 5 Radiotherapy, Intensity-Modulated 5 Magnetic Resonance Spectroscopy 5 Irinotecan 5 Folfox protocol 5 trifluridine tipiracil drug combination 4 pembrolizumab 4 Surgical Procedures, Operative 4 encorafenib 3 X-Rays 3 Trastuzumab 3 Surveys and Questionnaires 3 Sigmoidoscopy 3 Radiation 3 Pemetrexed 3 Gemcitabine 3 Endoscopy 3 Control Groups 3 Consolidation Chemotherapy 3 Cisplatin 3 Carboplatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Rectal Neoplasms × Mastectomy, Segmental × 90 days × Clear all

NCT06249672 2026-05-05

PRESERVE

Insel Gruppe AG, University Hospital Bern

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡